Level, phenotype and activation status of CD4+FoxP3+ regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus

Clinical and Experimental Immunology

Volumn 155, Issue 1, 2009, Pages 35-43

  Rallon N I ^a   Lopez M ^a   Soriano, V ^a   Garcia Samaniego J ^a   Romero, M ^a   Labarga, P ^a   Garcia Gasco P ^a   Gonzalez Lahoz J ^a   Benito, J M ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Activation; FoxP3; HIV HCV co infection; Regulatory T cells

Indexed keywords

CD27 ANTIGEN; CD38 ANTIGEN; CD45RA ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL LEVEL; CONTROLLED STUDY; FLOW CYTOMETRY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MIXED INFECTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV; HIV INFECTIONS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; PHENOTYPE; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 57449111288     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03797.x     Document Type: Article

References (51)

1. Koup RA, Safrit JT, Cao Y et al. Temporal association of cellular immune responses with the initial control of viremia in primary HIV type 1 syndrome. J Virol 1994 68 : 4650 5.
2. Schmitz J, Schmitz JE, Kuroda MJ et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999 283 : 857 60.
3. Missale G, Bertoni R, Lamonaca V et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996 98 : 706 14.
4. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001 194 : 1395 406.
5. Shankar P, Russo M, Harnisch B, Patterson M, Skolnik P, Lieberman J. Impaired function of circulating HIV-specific CD8+ T-cells in chronic HIV infection. Blood 2000 96 : 3094 101.
6. Benito JM, López M, Lozano S et al. Phenotype and functional characteristics of HIV-specific cytotoxic CD8+ T-cells in chronically infected patients. Dual effects of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003 34 : 255 66.
7. Wedemeyer H, He XS, Nascimbeni M et al. Impaired effector function of hepatitis C virus-specific CD8-T cells in chronic hepatitis C virus infection. J Immunol 2002 169 : 3447 58.
8. Ulsenheimer A, Gerlach JT, Gruener NH et al. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 2003 37 : 1189 98.
9. Benito JM, López M, Soriano V. The role of CD8+ T-cell response in HIV infection. AIDS Rev 2004 6 : 79 88.
10. Tortorella D, Gewurz BE, Furman MH, Schust DJ, Ploegh HL. Viral subversion of the immune system. Annu Rev Immunol 2000 18 : 861 926.
11. Baecher-Allan C, Viglietta V, Hafler D. Human CD4+CD25+ regulatory T cells. Semin Immunol 2004 16 : 89 98.
12. Dittmer U, He H, Messer RJ et al. Functional impairment of CD8+ T cells by regulatory T cells during persistent retroviral infection. Immunity 2004 20 : 293 303.
13. Cabrera R, Tu Z, Xu Y et al. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004 40 : 1062 71.
14. Robertson S, Hasenkrug K. The role of virus-induced regulatory T cells in immunopathology. Springer Semin Immunopathol 2006 28 : 51 62.
15. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 2001 193 : 1303 10.
16. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001 193 : 1285 94.
17. Stephens LA, Mottet C, Mason D, Powrie F. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 2001 31 : 1247 54.
18. Baecher-Allan C, Brown JA, Freeman GF, Hafler DA. CD4+CD25 high regulatory cells in human peripheral blood. J Immunol 2001 167 : 1245 53.
19. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004 10 : 801 5.
20. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003 3 : 253 7.
21. Vigouroux S, Yvon E, Biagi E, Brenner MK. Antigen-induced regulatory T cells. Blood 2004 104 : 26 33.
22. Aandahl EM, Michaëlsson J, Moretto WJ, Hecht FM, Nixon DF. Human CD4+ CD25+ regulatory T cells control T-cell responses to HIV and cytomegalovirus antigens. J Virol 2004 78 : 2454 9.
23. Kinter AL, Hennessey M, Bell A et al. CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 2004 200 : 331 43.
24. Sugimoto K, Ikeda F, Stadanlick J, Nunes FA, Alter HJ, Chang KM. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 2003 38 : 1437 48.
25. Weiss L, Donkova-Petrini V, Caccavelli L et al. V-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004 104 : 3249 56.
26. Tsunemi S, Iwasaki T, Imado T et al. Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients. AIDS 2005 19 : 879 86.
27. Boettler T, Spangenberg HC, Neumann-Haefelin C et al. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 2005 79 : 7860 7.
28. Boyer O, Saadoun D, Abriol J et al. CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 2004 103 : 3428 30.
29. Banham AH. Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells. Trends Immunol 2006 27 : 541 4.
30. Eggena MP, Barugahare B, Jones N et al. Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 2005 174 : 4407 14.
31. Annacker O, Pimenta-Araujo R, Burlen-Defranoux O, Barbosa TC, Cumano A, Bandeira A. CD25+CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol 2001 166 : 3008 18.
32. Liu W, Putnam AL, Xu-Yu Z et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells. J Exp Med 2006 203 : 1701 11.
33. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003 299 : 1057 61.
34. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003 4 : 330 6.
35. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 2005 22 : 329 41.
36. Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003 4 : 337 42.
37. Montes M, Lewis DE, Sanchez C et al. Foxp3+ regulatory T cells in antiretroviral-naive HIV patients. AIDS 2006 20 : 1669 71.
38. Kinter AL, Horak R, Sion M et al. CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro. AIDS Res Hum Retroviruses 2007 23 : 438 50.
39. Sereti I, Imamichi H, Natarajan V et al. In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients. J Clin Invest 2005 115 : 1839 47.
40. Manigold T, Shin EC, Mizukoshi E et al. Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C. Blood 2006 107 : 4424 32.
41. Ndhlovu L, Loo C, Spotts G, Nixon D, Hecht F. FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+CD8+ T cell activation levels in primary HIV-1 infection. J Leukoc Biol 2008 83 : 254 62.
42. Dejaco C, Duftner C, Schirmer M. Are regulatory T-cells linked with aging? Exp Gerontol 2006 41 : 339 45.
43. Epple HJ, Loddenkemper C, Kunkel D et al. Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 2006 108 : 3072 8.
44. Jiang Q, Zhang L, Wang R et al. Foxp3+CD4+ Treg cells play an important role in acute HIV-1 infection in humanized rag2-/-(gamma)C-/- mice in vivo. Blood 2008 112 : 2858 68 Epub ahead of print F, Sinistro A, Ciaprini C et al. Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels. Clin Exp Immunol 2006 144 : 188 96.
45. Hasenkrug K. CD4+ regulatory T cells in chronic viral infection. Novartis Found Symp 2003 252 : 194 9.
46. Seddiki N, Santner-Nanan B, Martinson J et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006 203 : 1693 700.
47. Li S, Jones KL, Woollard DJ et al. Defining target antigens for CD25+ FOXP3 + IFN-gamma- regulatory T cells in chronic hepatitis C virus infection. Immunol Cell Biol 2007 85 : 197 204.
48. Brenchley JM, Price DA, Schacker TW et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006 12 : 1365 71.
49. Benito JM, López M, Martín JC et al. Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or nonnucleoside reverse transcriptase inhibitors. AIDS Res Hum Retroviruses 2002 18 : 1379 88.
50. Oswald-Richter K, Grill SM, Shariat N et al. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol 2004 2 : E198.
51. Ondoa P, De Puydth H, Vereecken C et al. CD4+ T cell nadir and reconstitution of T regulatory cells in HIV-1-infected persons receiving HAART. 15th Conference on Retroviruses and Opportunistic Infections. Boston, 3-6 February 2008 [abstract 460 ].